In the week of 21 March to 26 March, 12,839 medtech jobs were posted worldwide by 332 companies, according to the GlobalData jobs analytics tool.
Bausch & Lomb was once again the most prolific hirer across the medtech industry, posting 1,304 jobs. It was followed by PPD Group, which made 856 listings, and Sonova Holding, which advertised for 738 positions.
Go deeper with GlobalData
Bausch & Lomb parent company Bausch Health completed the sale of is Egyptian drug unit Amoun Pharmaceutical to Abu Dhabi’s sovereign wealth fund ADQ for $740m this week, ahead of the planned separation of Bausch & Lomb from the rest of the organisation.
Bausch Health CEO Joseph Papa said: “The sale of Amoun marks significant progress in our efforts to reduce overall Bausch Health debt as we continue to pursue all opportunities to drive value for our shareholders, including preparing for the spinoff of Bausch & Lomb.”
FDA second-in-command steps down after two years
The US Food and Drug Administration has made headlines in the past week, following the resignation of its chief information officer and second-in-command Amy Abernathy. Abernathy, who oversaw tech and data modernisation at the FDA and has thus worked closely with parts of the medtech industry, is stepping down after only two years in the role.
Abernathy also launched the FDA’s Covid-19 accelerator project to boost real-world data gathering.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataHer departure comes as pressure mounts on President Joe Biden to appoint a permanent FDA head, two months into his administration. Abernathy was at one point considered a contender for the role.
In a series of tweets, Abernathy emphasised the importance of rethinking US digital health infrastructure, and noted that she was going to spend some time off with her family and would be “back at it soon”.
https://twitter.com/DrAbernethyFDA/status/1374433403332792326
